These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36273140)

  • 1. circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis.
    Ma H; Qu S; Zhai Y; Yang X
    Cell Mol Biol Lett; 2022 Oct; 27(1):94. PubMed ID: 36273140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p/SLC1A5 axis.
    Yuan M; Zhang J; He Y; Yi G; Rong L; Zheng L; Zhan T; Zhou C
    Arch Gynecol Obstet; 2022 Nov; 306(5):1643-1655. PubMed ID: 35284960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hsa_circ_0000518 Facilitates Non-Small-Cell Lung Cancer Progression via Moderating miR-330-3p and Positively Regulating SLC1A5.
    Lv H; Shi Z; Sui A; Zhang Y; Peng L; Wang M; Zhang F
    J Immunol Res; 2022; 2022():4996980. PubMed ID: 35874898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis.
    Wu B; Chen Y; Chen Y; Xie X; Liang H; Peng F; Che W
    Thorac Cancer; 2022 Jun; 13(12):1795-1805. PubMed ID: 35567340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
    Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
    J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis.
    Cai Y; Dong Z; Wang J
    World J Surg Oncol; 2022 Oct; 20(1):329. PubMed ID: 36192755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5.
    Luo H; Peng J; Yuan Y
    Cell Cycle; 2023 May; 22(10):1182-1195. PubMed ID: 35482822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression.
    Yang L; Wang L; Wu J; Wang Y
    Transpl Immunol; 2023 Apr; 77():101764. PubMed ID: 36462557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
    Wang J; Yang K; Cao J; Li L
    Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0072995 Promotes Ovarian Cancer Progression Through Regulating miR-122-5p/SLC1A5 Axis.
    Huang X; Luo Y; Li X
    Biochem Genet; 2022 Feb; 60(1):153-172. PubMed ID: 34132956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis.
    Zhang M; Sun Y; Xu H; Shi Y; Shen R; Teng F; Xu J; Jia X
    Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(4):574-586. PubMed ID: 37057923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating ACTN4 expression via miR-876-3p.
    Liang X; Liu X; Song Z; Zhu J; Zhang J
    Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1257-1269. PubMed ID: 35856314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa_circ_0001495 contributes to cervical cancer progression by targeting miR-526b-3p/TMBIM6/mTOR axis.
    Zhang X; Zheng X
    Reprod Biol; 2022 Jun; 22(2):100648. PubMed ID: 35533615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA hsa_circ_0018189 drives non-small cell lung cancer growth by sequestering miR-656-3p and enhancing xCT expression.
    Cai J; Zheng Y; Dong L; Zhang X; Huang Y
    J Clin Lab Anal; 2022 Nov; 36(11):e24714. PubMed ID: 36164726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
    Liu T; Yuan L; Zou X
    J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
    Zhang C; Li Y; Zhao W; Liu G; Yang Q
    Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F
    Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA circ-AGFG1 contributes to esophageal squamous cell carcinoma progression and glutamine catabolism by targeting microRNA-497-5p/solute carrier family 1 member 5 axis.
    Chen S; Liu Z; Feng Q; Zhou J; Huang J; Yu J
    Anticancer Drugs; 2023 Feb; 34(2):195-206. PubMed ID: 36206112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137.
    Xue M; Hong W; Jiang J; Zhao F; Gao X
    RNA Biol; 2020 Dec; 17(12):1811-1822. PubMed ID: 32658600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating PTEN expression.
    Han Y; Zheng Y; You J; Han Y; Lu X; Wang X; Shi C; Zhu W
    Clin Transl Oncol; 2023 Oct; 25(10):2901-2910. PubMed ID: 37000289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.